Literature DB >> 11757972

Cryptococcus neoformans infection in a cohort of Italian AIDS patients: natural history, early prognostic parameters, and autopsy findings.

S Antinori1, L Galimberti, C Magni, A Casella, L Vago, F Mainini, M Piazza, M Nebuloni, M Fasan, C Bonaccorso, G M Vigevani, A Cargnel, M Moroni, A Ridolfo.   

Abstract

This observational cohort study of 4,160 AIDS patients hospitalised in a single institution in northern Italy between January 1985 and December 1999 was carried out in order to assess the natural history of cryptococcosis, the epidemiological trend of this opportunistic infection, the risk factors predictive of death at 10 weeks, the response to therapy, and autopsy findings. Cryptococcosis was diagnosed in 177 (4.2%) patients and was the AIDS-defining disease in 2.8% of cases. Its prevalence decreased significantly over time (from 6.4% in the period 1985-1989 to 5.7% in 1990-1993, 3.1% in 1994-1996, and 1.9% in 1997-1999, P <0.0001). Although neurologic disease was the most frequent clinical picture, a significant proportion of the patients (24.2%) presented with extraneural cryptococcosis. In a Cox multivariate analysis, high titres of cerebrospinal fluid antigen (>5000) and drug addiction were predictive of death at 10 weeks. A complete clinical and mycological response was achieved in 60.8% of the treated patients, with the highest response rate being observed in those treated with amphotericin plus flucytosine (66.6%). Cryptococcosis relapsed in 12.8% of patients on secondary prophylaxis. Autopsy findings demonstrated that cryptococcosis is a disseminated disease, but long-term antifungal treatment may be able to eradicate it in a subgroup of patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757972     DOI: 10.1007/s100960100616

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  12 in total

1.  The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis.

Authors:  Spinello Antinori; Anna Radice; Laura Galimberti; Carlo Magni; Marco Fasan; Carlo Parravicini
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 2.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

3.  Refractory and/or Relapsing Cryptococcosis Associated with Acquired Immune Deficiency Syndrome: Clinical Features, Genotype, and Virulence Factors of Cryptococcus spp. Isolates.

Authors:  Erika Nascimento; Lucia H Vitali; Ludmilla Tonani; Marcia R Von Zeska Kress; Osvaldo M Takayanagui; Roberto Martinez
Journal:  Am J Trop Med Hyg       Date:  2016-02-29       Impact factor: 2.345

4.  Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings.

Authors:  Nina Singh; Olivier Lortholary; Françoise Dromer; Barbara D Alexander; Krishan L Gupta; George T John; Ramon del Busto; Goran B Klintmalm; Jyoti Somani; G Marshall Lyon; Kenneth Pursell; Valentina Stosor; Patricia Munoz; Ajit P Limaye; Andre C Kalil; Timothy L Pruett; Julia Garcia-Diaz; Atul Humar; Sally Houston; Andrew A House; Dannah Wray; Susan Orloff; Lorraine A Dowdy; Robert A Fisher; Joseph Heitman; Marilyn M Wagener; Shahid Husain
Journal:  Transplantation       Date:  2008-09-15       Impact factor: 4.939

5.  Predictors of outcome in routine care for Cryptococcal meningitis in Western Kenya: lessons for HIV outpatient care in resource-limited settings.

Authors:  Caroline Kendi; Jeremy Penner; Julius Koech; Mary Nyonda; Craig R Cohen; Elizabeth A Bukusi; Evelyn Ngugi; Ana-Claire Lew Meyer
Journal:  Postgrad Med J       Date:  2012-10-30       Impact factor: 2.401

6.  Epidemiological characterization and prognostic factors in patients with confirmed cerebral cryptococcosis in central Taiwan.

Authors:  Chang-Hua Chen; Hiu-Ngar Sy; Li-Jhen Lin; Hua-Cheg Yen; Shao-Hung Wang; Wei-Liang Chen; Yu-Min Chen; Yu-Jun Chang
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-05-12

Review 7.  New Insights into HIV/AIDS-Associated Cryptococcosis.

Authors:  Spinello Antinori
Journal:  ISRN AIDS       Date:  2013-02-25

8.  Cerebral Oximetry for Detecting High-mortality Risk Patients with Cryptococcal Meningitis.

Authors:  John W Diehl; Katherine H Hullsiek; Michael Okirwoth; Nicole Stephens; Mahsa Abassi; Joshua Rhein; David B Meya; David R Boulware; Abdu K Musubire
Journal:  Open Forum Infect Dis       Date:  2018-05-08       Impact factor: 3.835

9.  Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010.

Authors:  Hsiang-Kuang Tseng; Chang-Pan Liu; Mao-Wang Ho; Po-Liang Lu; Hsiu-Jung Lo; Yu-Hui Lin; Wen-Long Cho; Yee-Chun Chen
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

10.  Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.

Authors:  Françoise Dromer; Simone Mathoulin-Pélissier; Odile Launay; Olivier Lortholary
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.